GemVax Raises 52.1 Billion KRW Through Capital Increase and Convertible Bonds
On December 24, GemVax, a KOSDAQ-listed company, announced that it has decided to raise approximately 17 billion KRW in operating funds, including research and development expenses, through a third-party allotment capital increase. The recipients are Gem&Company, the largest shareholder, and Kim Kiho, CEO of GemVax.
On the same day, GemVax also announced that it would raise 35.1 billion KRW in operating funds, including research and development expenses, through the issuance of convertible bonds (CB). The maturity date for the bonds is January 23, 2029.
Hot Picks Today
Despite 10% Annual Interest, Russians Pull Out Cash as Fears of Deposit Nationalization Spread
- "Monami Posts a 10 Billion Won Deficit, But Consistently Awards 4.7 Billion Won in Contracts to the Third-Generation Family Company"
- "JP Morgan Highlights and Analyzes Additional Shareholder Returns, Urging 'Buy More SK hynix Even Now'"
- "Told to Clean, but Crashed Into Furniture"...Xiaomi Robot Vacuum Cleaner Faces Legal Dispute
- "Caught Sneaking Water from Baengnokdam at Dawn"... Jeju Deploys Thermal Imaging AI Drones on Hallasan
As a result, GemVax will have raised a total of 52.1 billion KRW in funds.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
